Diamond-Blackfan anemia: Clinical features and treatment results in 4 cases

Hematology

Volumn 11, Issue 3, 2006, Pages 193-195

  Naithani, Rahul ^a   Chandra, Jagdish ^a   Narayan, Shashi ^b   Singh, Varinder ^a   Dutta, A K ^a  

^a KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Cyclosporin A; Diamond Blackfan anemia; PRCA; Steroids

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; HEMOGLOBIN; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ARTICLE; BLACKFAN DIAMOND ANEMIA; CASE REPORT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLOW UP; HEPATOMEGALY; HUMAN; LOW DRUG DOSE; MALE; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; REMISSION; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANEMIA, DIAMOND-BLACKFAN; CHILD, PRESCHOOL; CYCLOSPORINE; DEXAMETHASONE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PREDNISOLONE; REMISSION INDUCTION;

EID: 33748514367     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600774777     Document Type: Article

References (12)

1. Marwaha, RK and Bansal, D and Trehan, A and Marwaha, N and Varma, N. (2002) Clinico-haematological profile of pure red cell aplasia in children J Trop Pediatr, 48, pp. 113-116.
2. Fisch, P. (2000) Pure red cell aplasia Br J Haematol, 111, pp. 1010-1022.
3. Marmont, AM. (1991) Therapy of pure red cell aplasia Semin Hematol, 91, pp. 285-297.
4. Kwong, YL and Wong, KF and Liang, RHS and Chu, YC and Chan, LC and Chan, TK. (1996) Pure red cell: Clinical features and treatment results in 16 cases Ann Hematol, 72, pp. 137-140.
5. Sato, N and Takatani, O and Hosoi, T and (1989) Treatment of pure red cell aplasia that is resistant to conventional immunosuppressive therapy with intermittent administration of methotrexate Acta Hematol, 82, pp. 98-101.
6. Firkin, FC and Maher, D. (1988) Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia Eur J Haematol, 41, pp. 212-217.
7. Marmont, AM and Peschle, C and Sanguineti, M and Condorellei, M. (1975) Pure red cell aplasia: Response of three patients to cyclophosphamide and/or antilymphocyte globulin and demonstration of two types of serum IgG inhibitors to erythropoiesis Blood, 45, pp. 247-261.
8. Clark, DA and Dessypriss, EN and Krantz, SB. (1984) Studies on pure red cell aplasia XI. Results of immunosuppressive ttreatment of 37 patients Blood, 63, pp. 277-286.
9. Mamiya, S and Itoh, T and Miura, AB. (1997) Acquired pure red cell aplasia in Japan Eur J Haematol, 59, pp. 199-205.
10. Raghavachar, A. (1990) Pure red cell aplasia: Review of treatment and proposal for a treatment strategy Blood, 61, pp. 47-51.
11. Williams, DL and Mageed, ASA and Findley, H and Ragab, AH. (1987) Cyclosporin in the treatment of red cell aplasia Am J Pediatr Hematol Oncol, 9, pp. 314-316.
12. Ozsoylu, S. (1988) High dose intravenous corticosteroids treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventional treatment Am J Pediatr Hematol Oncol, 10, pp. 217-231.